Keyword: Brigham and Women's Hospital
Should drugs that win conditional FDA approval command the same high prices as products that undergo the full menu of agency scrutiny?
Novartis' slow-starting heart failure med Entresto reduced patients' blood sugar levels more than a head-to-head rival did, a new analysis shows.
Researchers from MIT and Brigham and Women’s Hospital have developed a nanotech-based treatment to deliver obesity drugs to fat tissue with minimal side effects. Drug delivery guru Robert Langer of MIT helped lead the research.
U.S. researchers have developed a pill that can slowly release its dose over time while attached to the lining of the gastrointestinal tract.